SHE:301246 - Hubei Hongyuan Pharmaceutical Technology Co Ltd

Hubei Hongyuan Pharmaceutical
Sector: Health Care, Industry: Pharmaceuticals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2012 Q4	2013 Q4	2014 Q4	2015 Q2	2015 Q4	2016 Q2	2018 Q4	2019 Q4	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	0% -	0% -	0% -	-	60.84% -
Net Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	31.95% 30.3%	31.24% -2.2%	31.3% 0.2%	34.76% 11.1%	33.6% -3.3%	26.65% -20.7%	21.07% -21.0%	15.25% -27.6%	9.13% -40.1%	6.93% -24.1%	4.24% -38.8%	2.71% -36.1%
Gross Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-23.22% -	42.46% -	33.64% -20.8%	38.08% 13.2%	29.07% -23.7%	43.24% 48.7%	23.32% -46.1%	20.59% -11.7%	17.83% -13.4%	16.91% -5.2%	12.99% -23.2%	11.98% -7.8%
Operating Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-45.15% -	32.49% -	23.74% -27.0%	28.84% 21.5%	21.28% -26.2%	34.77% 63.4%	15.98% -54.0%	14.42% -9.7%	10.96% -24.0%	10.01% -8.7%	5.37% -46.4%	3% -44.1%
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	360.77M 6.7%	1.39B 286.4%	1.58B 13.2%	1.69B 7.2%	1.78B 5.3%	1.84B 3.6%	2.06B 11.9%	2.12B 2.6%	2.16B 2.1%	2.29B 5.9%	2.05B -10.2%	1.98B -3.8%
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.94B -	2.2B 13.6%	2.43B 10.5%	2.95B 21.4%	3.29B 11.3%	3.56B 8.4%	3.88B 8.8%	5.95B 53.4%	5.71B -4.0%	5.56B -2.6%	5.65B 1.6%	5.64B -0.2%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	555.65M -	642.71M 15.7%	754.27M 17.4%	1.1B 45.5%	1.3B 18.9%	1.51B 15.7%	1.76B 16.7%	1.57B -10.8%	1.37B -12.6%	1.19B -13.3%	1.29B 8.4%	1.25B -3.3%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.38B -	1.56B 12.7%	1.68B 7.6%	1.85B 10.5%	1.98B 6.8%	2.05B 3.5%	2.11B 3.1%	4.38B 107.0%	4.34B -0.9%	4.37B 0.8%	4.36B -0.2%	4.39B 0.7%
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	106.92M -	-	196.1M -	-	201.58M -	-	214.99M -	-	-7.7M -	-	35.25M -	-
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	224.27M -	-	224.27M -	95.78M -57.3%	140.08M 46.3%	328.93M 134.8%	95.78M -70.9%	297.89M 211.0%	328.93M 10.4%	295.7M -10.1%	236.72M -19.9%	2.33B 883.5%
End Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	140.08M -	-	95.78M -	297.89M 211.0%	328.02M 10.1%	295.7M -9.9%	236.72M -19.9%	2.32B 881.6%	189.25M -91.9%	822.13M 334.4%	356.4M -56.6%	518.81M 45.6%
Free Cash Flow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-47.8M -	114.92M -	-62.92M -	-15.21M -	-313.51M -	-57.8M -	-292.1M -	-339.61M -	-323.87M -	-179.06M -	-439.39M -	-547.93M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	198.11M -	-	493.85M -	-	598.28M -	-	434.8M -	-	197.28M -	-	87.17M -	-
Diluted Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-	-
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.327 39.1%	1.235 278.1%	1.4 13.3%	1.666 19.0%	1.7 2.0%	1.394 -18.0%	1.23 -11.8%	0.91 -26.0%	0.606 -33.4%	0.425 -29.9%	0.225 -47.1%	0.123 -45.1%
Return On Equity (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	8.33% -	27.93% 235.1%	34.51% 23.5%	31.69% -8.2%	35.57% 12.3%	27.24% -23.4%	22.93% -15.8%	10.36% -54.8%	6.25% -39.7%	4.94% -20.9%	2.69% -45.5%	1.22% -54.6%
Return On Assets (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	5.95% -	19.78% 232.6%	23.61% 19.4%	19.91% -15.7%	22.91% 15.1%	17.07% -25.5%	13.79% -19.2%	7.25% -47.4%	4.39% -39.5%	3.48% -20.7%	1.83% -47.4%	0.93% -49.4%